Literature DB >> 16603932

Aggregate distribution in frontal and motor cortex in Huntington's disease brain.

Willeke M C van Roon-Mom1, Virginia M Hogg, Lynette J Tippett, Richard L M Faull.   

Abstract

Insoluble protein aggregates have been considered a pathological hallmark of Huntington's disease and other polyglutamine disorders. In this study the number of aggregates was assessed in the superior frontal gyrus and motor cortex of seven Huntington's disease patients and was compared with the symptoms (motor/mood) these patients displayed during the course of the disease. Regardless of the pattern of symptoms present in the patients, there was a consistently higher number of nuclear and non-nuclear aggregates in the superior frontal gyrus than in the motor cortex. This suggests that there is a consistent regional difference in the density of aggregates and that this consistency is not reflected in the variable symptomatology between cases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16603932     DOI: 10.1097/00001756-200604240-00022

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  5 in total

Review 1.  Choosing an animal model for the study of Huntington's disease.

Authors:  Mahmoud A Pouladi; A Jennifer Morton; Michael R Hayden
Journal:  Nat Rev Neurosci       Date:  2013-10       Impact factor: 34.870

Review 2.  Genetics and neuropathology of Huntington's disease.

Authors:  Anton Reiner; Ioannis Dragatsis; Paula Dietrich
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

3.  Epigenetic dysregulation of hairy and enhancer of split 4 (HES4) is associated with striatal degeneration in postmortem Huntington brains.

Authors:  Guang Bai; Iris Cheung; Hennady P Shulha; Joana E Coelho; Ping Li; Xianjun Dong; Mira Jakovcevski; Yumei Wang; Anastasia Grigorenko; Yan Jiang; Andrew Hoss; Krupal Patel; Ming Zheng; Evgeny Rogaev; Richard H Myers; Zhiping Weng; Schahram Akbarian; Jiang-Fan Chen
Journal:  Hum Mol Genet       Date:  2014-12-05       Impact factor: 6.150

4.  Neuroanatomic profile of polyglutamine immunoreactivity in Huntington disease brains.

Authors:  Emily S Herndon; Christa L Hladik; Ping Shang; Dennis K Burns; Jack Raisanen; Charles L White
Journal:  J Neuropathol Exp Neurol       Date:  2009-03       Impact factor: 3.685

5.  The distribution and density of Huntingtin inclusions across the Huntington disease neocortex: regional correlations with Huntingtin repeat expansion independent of pathologic grade.

Authors:  Richard A Hickman; Phyllis L Faust; Karen Marder; Ai Yamamoto; Jean-Paul Vonsattel
Journal:  Acta Neuropathol Commun       Date:  2022-04-19       Impact factor: 7.578

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.